Literature DB >> 15649894

Identification and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters.

Frank Visser1, Stephen A Baldwin, R Elwyn Isaac, James D Young, Carol E Cass.   

Abstract

The equilibrative nucleoside transporters, hENT1 and CeENT1 from humans and Caenorhabditis elegans, respectively, are inhibited by nanomolar concentrations of dipyridamole and share a common 11-transmembrane helix (TM) topology. Random mutagenesis and screening by functional complementation in yeast for clones with reduced sensitivities to dipyridamole yielded mutations at Ile429 in TM 11 of CeENT1 and Met33 in TM 1 of hENT1. Mutational analysis of the corresponding residues of both proteins suggested important roles for these residues in competitive inhibition of hENT1 and CeENT1 by dipyridamole. To verify the roles of these residues in dipyridamole interactions, hENT2, which naturally exhibits low dipyridamole sensitivity, was mutated to contain side chains favorable for high affinity dipyridamole binding (i.e. a Met at the TM 1 and/or an Ile at the TM 11 positions). The single mutants exhibited increased hENT2 sensitivity to inhibition by dipyridamole, and the double mutant was the most sensitive, with an IC50 value that was only 2% of that of wild type. Functional analysis of the TM 1 and 11 mutants of hENT1 and CeENT1 revealed that Ala and Thr in the TM 1 and 11 positions, respectively, impaired uridine and adenosine transport and that Leu442 of hENT1 was involved in permeant selectivity. Mechanistic and structural models of dipyridamole interactions with the TM 1 and 11 residues are proposed. This study demonstrated that the corresponding residues in TMs 1 and 11 of hENT1, hENT2, and CeENT1 are important for dipyridamole interactions and nucleoside transport.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649894     DOI: 10.1074/jbc.M410348200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors: IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORS.

Authors:  Vijaya L Damaraju; Dwayne Weber; Michelle Kuzma; Carol E Cass; Michael B Sawyer
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

2.  Transmembrane segment 11 appears to line the purine permeation pathway of the Plasmodium falciparum equilibrative nucleoside transporter 1 (PfENT1).

Authors:  Paul M Riegelhaupt; I J Frame; Myles H Akabas
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

3.  Functional characterization and expression analysis of a gene, OsENT2, encoding an equilibrative nucleoside transporter in rice suggest a function in cytokinin transport.

Authors:  Naoya Hirose; Nobue Makita; Tomoyuki Yamaya; Hitoshi Sakakibara
Journal:  Plant Physiol       Date:  2005-04-22       Impact factor: 8.340

4.  An ab Initio structural model of a nucleoside permease predicts functionally important residues.

Authors:  Raquel Valdés; Shirin Arastu-Kapur; Scott M Landfear; Ujwal Shinde
Journal:  J Biol Chem       Date:  2009-05-08       Impact factor: 5.157

Review 5.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

6.  Cysteine cross-linking defines the extracellular gate for the Leishmania donovani nucleoside transporter 1.1 (LdNT1.1).

Authors:  Raquel Valdés; Ujwal Shinde; Scott M Landfear
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

7.  Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells.

Authors:  Eric I Zimmerman; Min Huang; Andrea V Leisewitz; Yanhong Wang; Jing Yang; Lee M Graves
Journal:  FEBS Lett       Date:  2008-12-29       Impact factor: 4.124

8.  Role of transmembrane domain 4 in ligand permeation by Crithidia fasciculata equilibrative nucleoside transporter 2 (CfNT2).

Authors:  Cassandra S Arendt; Buddy Ullman
Journal:  J Biol Chem       Date:  2009-12-26       Impact factor: 5.157

9.  Structures of human ENT1 in complex with adenosine reuptake inhibitors.

Authors:  Nicholas J Wright; Seok-Yong Lee
Journal:  Nat Struct Mol Biol       Date:  2019-06-24       Impact factor: 15.369

10.  High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva.

Authors:  Serena Cappato; Laura Tonachini; Francesca Giacopelli; Mario Tirone; Luis J V Galietta; Martina Sormani; Anna Giovenzana; Antonello E Spinelli; Barbara Canciani; Silvia Brunelli; Roberto Ravazzolo; Renata Bocciardi
Journal:  Dis Model Mech       Date:  2016-04-28       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.